Rituximab for High-Risk, Mature B-Cell Non-Hodgkin’s Lymphoma in Children

Original Article

V. Minard-Colin, A. Aupérin, M. Pillon, G.A. Burke, D.A. Barkauskas, K. Wheatley, R.F. Delgado, S. Alexander, A. Uyttebroeck, C.M. Bollard, J. Zsiros, M. Csoka, B. Kazanowska, A.K. Chiang, R.R. Miles, A. Wotherspoon, P.C. Adamson, G. Vassal, C. Patte, and T.G. Gross

N Engl J Med 2020;382:2207-2219

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
06/03/2020
Course expires: 
06/04/2022

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Course closed

This course closed on Saturday, June 4, 2022 - 11:59pm.